News Channels

25 Jun 2018 Merrimack Announces Top-Line Results from Randomized Phase 2 Trial of MM-141 in Front-Line Metastatic Pancreatic Cancer
25 Jun 2018 Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE® (Palbociclib) in HR+, HER2- Metastatic Breast Cancer
25 Jun 2018 AbbVie and Calibr announce collaboration for next generation T-cell therapies
25 Jun 2018 GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce FDA Approval of EPIDIOLEX® (cannabidiol) oral solution – the First Plant-derived Cannabinoid Prescription Medicine
25 Jun 2018 Real-World Data Show Advantages in People Treated with Lilly's Once-Weekly Trulicity® (dulaglutide) Compared to Those Treated with Liraglutide and Exenatide QW
25 Jun 2018 CellCentric enters clinic with first-in-class p300/CBP inhibitor for late-stage prostate cancer
25 Jun 2018 Genentech’s TECENTRIQ in Combination with Chemotherapy Helped People with Previously-Untreated Extensive-Stage Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy
24 Jun 2018 Ironwood Presents Praliciguat Phase IIa Study Data Showing Positive Impact on Metabolic and Cardiovascular Clinical Endpoints at the American Diabetes Association’s 78th Scientific Sessions
24 Jun 2018 Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to-Control Type 2 Diabetes
24 Jun 2018 Oral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial
22 Jun 2018 Ironwood Pharmaceuticals Initiates Pivotal Phase III Program for IW-3718 in Persistent Gastroesophageal Reflux Disease
22 Jun 2018 Revance Doses First Patient in ASPEN Phase 3 Clinical Program of RT002 Injectable for the Treatment of Cervical Dystonia
22 Jun 2018 Mezzion Pharma and NHLBI-Funded Pediatric Heart Network Complete Enrollment in a Pivotal Phase 3 Clinical Trial of Udenafil in Adolescents with Fontan Surgical Palliation - an Orphan Drug Indication
22 Jun 2018 Nanobiotix announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3
22 Jun 2018 U.S. Food and Drug Administration (FDA) Accepts Application for Opdivo Plus Low-Dose Yervoy for Treatment of First-Line Non-Small Cell Lung Cancer in Patients with Tumor Mutational Burden ≥10 mut/Mb
21 Jun 2018 Servier and Taiho Announce Phase III Trial Data Demonstrates Significant Overall Survival Benefit of LONSURF® (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
21 Jun 2018 Heron Announces Positive Topline Results from Phase 2b Clinical Studies of HTX-011 in Total Knee Arthroplasty and Breast Augmentation
21 Jun 2018 Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor
21 Jun 2018 Incyte Announces REACH1 Pivotal Trial Meets Primary Endpoint of Overall Response Rate for Ruxolitinib (Jakafi®) in Steroid-Refractory Acute Graft-Versus-Host Disease
21 Jun 2018 TxCell: First In vivo Proof-of-Concept Data with CD8+ CAR-Treg Presented at FOCIS 2018

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up